Cargando…

Anti-amyloid therapies work for Alzheimer’s disease

Detalles Bibliográficos
Autor principal: Hardy, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10365829/
https://www.ncbi.nlm.nih.gov/pubmed/37492486
http://dx.doi.org/10.1093/braincomms/fcad204
_version_ 1785077043962052608
author Hardy, John
author_facet Hardy, John
author_sort Hardy, John
collection PubMed
description
format Online
Article
Text
id pubmed-10365829
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-103658292023-07-25 Anti-amyloid therapies work for Alzheimer’s disease Hardy, John Brain Commun Letter to the Editor Oxford University Press 2023-07-17 /pmc/articles/PMC10365829/ /pubmed/37492486 http://dx.doi.org/10.1093/braincomms/fcad204 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of the Guarantors of Brain. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letter to the Editor
Hardy, John
Anti-amyloid therapies work for Alzheimer’s disease
title Anti-amyloid therapies work for Alzheimer’s disease
title_full Anti-amyloid therapies work for Alzheimer’s disease
title_fullStr Anti-amyloid therapies work for Alzheimer’s disease
title_full_unstemmed Anti-amyloid therapies work for Alzheimer’s disease
title_short Anti-amyloid therapies work for Alzheimer’s disease
title_sort anti-amyloid therapies work for alzheimer’s disease
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10365829/
https://www.ncbi.nlm.nih.gov/pubmed/37492486
http://dx.doi.org/10.1093/braincomms/fcad204
work_keys_str_mv AT hardyjohn antiamyloidtherapiesworkforalzheimersdisease